nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—HTR1B—Signaling Pathways—INS—atherosclerosis	0.00013	0.00013	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—LPL—atherosclerosis	0.00013	0.00013	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	0.00013	0.00013	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PLG—atherosclerosis	0.000129	0.000129	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IGF1—atherosclerosis	0.000129	0.000129	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PRKCG—atherosclerosis	0.000128	0.000128	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCL2—atherosclerosis	0.000128	0.000128	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ESR1—atherosclerosis	0.000127	0.000127	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GPX1—atherosclerosis	0.000127	0.000127	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	0.000127	0.000127	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SPP1—atherosclerosis	0.000127	0.000127	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	0.000126	0.000126	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CXCL8—atherosclerosis	0.000126	0.000126	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IGF1—atherosclerosis	0.000126	0.000126	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PDGFB—atherosclerosis	0.000126	0.000126	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—F2—atherosclerosis	0.000126	0.000126	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SPP1—atherosclerosis	0.000125	0.000125	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CXCL8—atherosclerosis	0.000124	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CD36—atherosclerosis	0.000124	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AGT—atherosclerosis	0.000123	0.000123	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—APOB—atherosclerosis	0.000123	0.000123	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—AKT1—atherosclerosis	0.000122	0.000122	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—SERPINE1—atherosclerosis	0.000122	0.000122	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	0.000122	0.000122	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000122	0.000122	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PIK3CG—atherosclerosis	0.000121	0.000121	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	0.000121	0.000121	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—APOE—atherosclerosis	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—LEP—atherosclerosis	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PIK3CG—atherosclerosis	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—SERPINE1—atherosclerosis	0.00012	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CAV1—atherosclerosis	0.000119	0.000119	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—APOA1—atherosclerosis	0.000119	0.000119	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	0.000118	0.000118	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PDGFB—atherosclerosis	0.000117	0.000117	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	0.000117	0.000117	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—MTHFR—atherosclerosis	0.000117	0.000117	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—LPL—atherosclerosis	0.000117	0.000117	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PPARG—atherosclerosis	0.000117	0.000117	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NOS3—atherosclerosis	0.000117	0.000117	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—MAPK3—atherosclerosis	0.000115	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PPARA—atherosclerosis	0.000115	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ESR1—atherosclerosis	0.000115	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—INS—atherosclerosis	0.000115	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AGT—atherosclerosis	0.000115	0.000115	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NOS3—atherosclerosis	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—AKT1—atherosclerosis	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APOB—atherosclerosis	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—INS—atherosclerosis	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—F2—atherosclerosis	0.000113	0.000113	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000113	0.000113	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AGT—atherosclerosis	0.000113	0.000113	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—LEP—atherosclerosis	0.000112	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—APOE—atherosclerosis	0.000112	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	0.000112	0.000112	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCL2—atherosclerosis	0.000112	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AGT—atherosclerosis	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CAV1—atherosclerosis	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—APOA1—atherosclerosis	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—LEP—atherosclerosis	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—APOE—atherosclerosis	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IGF1—atherosclerosis	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	0.000109	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—APOE—atherosclerosis	0.000109	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—LPL—atherosclerosis	0.000109	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CG—atherosclerosis	0.000109	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CAV1—atherosclerosis	0.000108	0.000108	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—APOA1—atherosclerosis	0.000108	0.000108	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ESR1—atherosclerosis	0.000107	0.000107	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—F2—atherosclerosis	0.000106	0.000106	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	0.000106	0.000106	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	0.000106	0.000106	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—ALB—atherosclerosis	0.000105	0.000105	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SERPINE1—atherosclerosis	0.000105	0.000105	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—F2—atherosclerosis	0.000104	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	0.000104	0.000104	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CXCL8—atherosclerosis	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—INS—atherosclerosis	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CG—atherosclerosis	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CXCL8—atherosclerosis	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—NOS3—atherosclerosis	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AGT—atherosclerosis	0.0001	0.0001	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—AKT1—atherosclerosis	9.99e-05	9.99e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NOS3—atherosclerosis	9.98e-05	9.98e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	9.98e-05	9.98e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	9.94e-05	9.94e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CG—atherosclerosis	9.85e-05	9.85e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—IL6—atherosclerosis	9.83e-05	9.83e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—APOE—atherosclerosis	9.82e-05	9.82e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—LEP—atherosclerosis	9.82e-05	9.82e-05	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—AKT1—atherosclerosis	9.78e-05	9.78e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	9.73e-05	9.73e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—MAPK3—atherosclerosis	9.71e-05	9.71e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	9.71e-05	9.71e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—IL6—atherosclerosis	9.63e-05	9.63e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—INS—atherosclerosis	9.6e-05	9.6e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	9.55e-05	9.55e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	9.54e-05	9.54e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PPARG—atherosclerosis	9.5e-05	9.5e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—INS—atherosclerosis	9.44e-05	9.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCL2—atherosclerosis	9.44e-05	9.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	9.44e-05	9.44e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	9.37e-05	9.37e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MMP9—atherosclerosis	9.35e-05	9.35e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—INS—atherosclerosis	9.32e-05	9.32e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AGT—atherosclerosis	9.31e-05	9.31e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	9.29e-05	9.29e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IGF1—atherosclerosis	9.28e-05	9.28e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—AKT1—atherosclerosis	9.27e-05	9.27e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—F2—atherosclerosis	9.26e-05	9.26e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NFKB1—atherosclerosis	9.25e-05	9.25e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTGS2—atherosclerosis	9.2e-05	9.2e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MMP9—atherosclerosis	9.16e-05	9.16e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	9.13e-05	9.13e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APOE—atherosclerosis	9.12e-05	9.12e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—LEP—atherosclerosis	9.12e-05	9.12e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MAPK8—atherosclerosis	9.1e-05	9.1e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—AKT1—atherosclerosis	9.07e-05	9.07e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NFKB1—atherosclerosis	9.06e-05	9.06e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	9.04e-05	9.04e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	9.02e-05	9.02e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	9.01e-05	9.01e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MAPK8—atherosclerosis	8.91e-05	8.91e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—AKT1—atherosclerosis	8.88e-05	8.88e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	8.86e-05	8.86e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CXCL8—atherosclerosis	8.85e-05	8.85e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	8.81e-05	8.81e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	8.71e-05	8.71e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	8.67e-05	8.67e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—F2—atherosclerosis	8.6e-05	8.6e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	8.55e-05	8.55e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ALB—atherosclerosis	8.55e-05	8.55e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	8.49e-05	8.49e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	8.42e-05	8.42e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	8.42e-05	8.42e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—VEGFA—atherosclerosis	8.4e-05	8.4e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—INS—atherosclerosis	8.39e-05	8.39e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—STAT3—atherosclerosis	8.32e-05	8.32e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	8.28e-05	8.28e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	8.25e-05	8.25e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	8.23e-05	8.23e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—VEGFA—atherosclerosis	8.22e-05	8.22e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—NOS3—atherosclerosis	8.17e-05	8.17e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—STAT3—atherosclerosis	8.14e-05	8.14e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	8.11e-05	8.11e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	8.01e-05	8.01e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	7.99e-05	7.99e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MAPK3—atherosclerosis	7.95e-05	7.95e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	7.92e-05	7.92e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	7.89e-05	7.89e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—INS—atherosclerosis	7.79e-05	7.79e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	7.79e-05	7.79e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MAPK3—atherosclerosis	7.78e-05	7.78e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	7.76e-05	7.76e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	7.72e-05	7.72e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TGFB1—atherosclerosis	7.71e-05	7.71e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	7.71e-05	7.71e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	7.67e-05	7.67e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	7.6e-05	7.6e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TGFB1—atherosclerosis	7.55e-05	7.55e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	7.54e-05	7.54e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTGS2—atherosclerosis	7.48e-05	7.48e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	7.46e-05	7.46e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	7.36e-05	7.36e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	7.35e-05	7.35e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	7.23e-05	7.23e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	7.21e-05	7.21e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	7.19e-05	7.19e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	7.16e-05	7.16e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	7.15e-05	7.15e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	7.12e-05	7.12e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	7.1e-05	7.1e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	7.1e-05	7.1e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	7.03e-05	7.03e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	7.01e-05	7.01e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	6.99e-05	6.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	6.84e-05	6.84e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	6.8e-05	6.8e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	6.75e-05	6.75e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	6.68e-05	6.68e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	6.64e-05	6.64e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	6.6e-05	6.6e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	6.57e-05	6.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	6.57e-05	6.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	6.55e-05	6.55e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	6.53e-05	6.53e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	6.49e-05	6.49e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	6.46e-05	6.46e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	6.44e-05	6.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	6.43e-05	6.43e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	6.3e-05	6.3e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	6.21e-05	6.21e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	6.14e-05	6.14e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	6.06e-05	6.06e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	6.06e-05	6.06e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	6e-05	6e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	5.97e-05	5.97e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	5.96e-05	5.96e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	5.91e-05	5.91e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	5.9e-05	5.9e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	5.86e-05	5.86e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	5.84e-05	5.84e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL6—atherosclerosis	5.81e-05	5.81e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	5.77e-05	5.77e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	5.74e-05	5.74e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	5.74e-05	5.74e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	5.72e-05	5.72e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL6—atherosclerosis	5.69e-05	5.69e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	5.64e-05	5.64e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	5.56e-05	5.56e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	5.48e-05	5.48e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	5.48e-05	5.48e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	5.43e-05	5.43e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AKT1—atherosclerosis	5.36e-05	5.36e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	5.33e-05	5.33e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	5.32e-05	5.32e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	5.3e-05	5.3e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	5.25e-05	5.25e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AKT1—atherosclerosis	5.25e-05	5.25e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	5.01e-05	5.01e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL6—atherosclerosis	4.97e-05	4.97e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	4.92e-05	4.92e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	4.88e-05	4.88e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	4.86e-05	4.86e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	4.66e-05	4.66e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AKT1—atherosclerosis	4.63e-05	4.63e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	4.59e-05	4.59e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	4.52e-05	4.52e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL6—atherosclerosis	4.49e-05	4.49e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL6—atherosclerosis	4.19e-05	4.19e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	4.14e-05	4.14e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL6—atherosclerosis	4.13e-05	4.13e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	3.87e-05	3.87e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	3.81e-05	3.81e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AKT1—atherosclerosis	3.76e-05	3.76e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL6—atherosclerosis	3.67e-05	3.67e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL6—atherosclerosis	3.41e-05	3.41e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	3.38e-05	3.38e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	3.14e-05	3.14e-05	CbGpPWpGaD
